Patient Preferences for Oral Anticoagulation Therapy in Atrial Fibrillation: A Systematic Literature Review

Objectives Since the introduction of non-vitamin K antagonist (VKA) oral anticoagulants (NOACs), an additional treatment option, apart from VKAs, has become available for stroke prevention in patients with atrial fibrillation (AF). For various reasons, it is important to consider patients’ preferenc...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The patient : patient-centered outcomes research Ročník 10; číslo 1; s. 17 - 37
Hlavní autori:	Wilke, Thomas, Bauer, Sabine, Mueller, Sabrina, Kohlmann, Thomas, Bauersachs, Rupert
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Cham Springer International Publishing 01.02.2017 Springer Nature B.V
Predmet:	Administration, Oral Adult Aged Aged, 80 and over Anticoagulants Anticoagulants - therapeutic use Atrial Fibrillation - drug therapy Cardiac arrhythmia Clinical decision making Clinical practice guidelines Decision making Drug therapy Evidence-based medicine Female Health Administration Health Economics Humans Male Medicine Medicine & Public Health Middle Aged Patient Preference - psychology Patients Pharmacoeconomics and Health Outcomes Public Health Quality of Life Research Risk Assessment Risk Factors Stroke Stroke - prevention & control Systematic Review Stroke Risk Rivaroxaban Bleeding Risk Atrial Fibrillation Apixaban
ISSN:	1178-1653, 1178-1661
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!